Débora Sant'ANna

Débora Sant'ANna

Auto-generated profile, based on publicly available information

Débora Sant'ANna

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
LSLais Roberta Deroldo Sommaggio
Lais Roberta Deroldo Sommaggio
DMDânia Elisa Christofoletti Mazzeo
Dânia Elisa Christofoletti Mazzeo
DADébora de Andrade e Silva Sant’ Anna
Débora de Andrade e Silva Sant’ Anna
CLCarlos Emílio Levy
Carlos Emílio Levy
MMMaria Aparecida Marin-Morales
Maria Aparecida Marin-Morales

8 April 2023 in Pathobiology
Verified
Journal Article
Closed access
PDF file
RCRodrigo de Oliveira Cavagna
Rodrigo de Oliveira Cavagna
IPIcaro Alves Pinto
Icaro Alves Pinto
FPFlávia Escremim de Paula
Flávia Escremim de Paula
GBGustavo Noriz Berardinelli
Gustavo Noriz Berardinelli
DSDébora Sant'ANna
Débora Sant'ANna
RRRui M. Reis
Rui M. Reis
Introduction: TP53 is the most frequently mutated gene in lung tumors, but its prognostic role in admixed populations, such as Brazilians, remains unclear. In this study, we aimed to evaluate the frequency and clinicopathological impact of TP53 mutations in non-small cell lung cancer (NSCLC) patients in Brazil. Methods: We analyzed 446 NSCLC patients from Barretos Cancer Hospital. TP53 mutational status was evaluated through targeted next-generation sequencing (NGS) and the variants were biologically classified as disruptive/nondisruptive and as truncating/nontruncating. We also assessed genetic ancestry using 46 ancestry-informative markers. Analysis of lung adenocarcinomas from the cBioportal dataset was performed. We further examined associations of TP53 mutations with patients’ clinicopathological features. Results: TP53 mutations were detected in 64.3% (n = 287/446) of NSCLC cases, with a prevalence of 60.4% (n = 221/366) in lung adenocarcinomas. TP53 mutations were associated with brain metastasis at diagnosis, tobacco consumption, and higher African ancestry. Disruptive and truncating mutations were associated with a younger age at diagnosis. Additionally, cBioportal dataset revealed that TP53 mutations were associated with younger age and Black skin color. Patients harboring disruptive/truncating TP53 mutations had worse overall survival than nondisruptive/nontruncating and wild-type patients. Conclusion: TP53 mutations are common in Brazilian lung adenocarcinomas, and their biological characterization as disruptive and truncating mutations is associated with African ancestry and shorter overall survival.

1 December 2021 in JCO Global Oncology
Verified
Journal Article
Open access
RCRodrigo Cavagna
Rodrigo Cavagna
FPFlávia Escremim de Paula
Flávia Escremim de Paula
DSDébora Sant'Anna
Débora Sant'Anna
ISIara Santana
Iara Santana
VSVinicius Duval da Silva
Vinicius Duval da Silva
RRRui M. Reis
Rui M. Reis


1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
RVRené Aloisio da Costa Vieira
René Aloisio da Costa Vieira
DSDébora Sant'ANna
Débora Sant'ANna
ALAna Carolina Laus
Ana Carolina Laus
RRRui M. Reis
Rui M. Reis
This study aimed to evaluate the association between self-reported race/color and ancestry in Brazilian patients with breast cancer.

1 June 2025 in JCO Global Oncology
Verified
Journal Article
Closed access
ACAna Carolina de Carvalho
Ana Carolina de Carvalho
ALAna Carolina Laus
Ana Carolina Laus
HJHoward Ribeiro Lopes Junior
Howard Ribeiro Lopes Junior
JPJun Porto
Jun Porto
DSDébora Sant'ANna Silva
Débora Sant'ANna Silva
RRRui M. Reis
Rui M. Reis
PURPOSE: Genome-wide association studies have identified several single-nucleotide polymorphisms (SNPs) linked to colorectal cancer (CRC) risk in European and Asian populations, but studies in admixed populations, like Brazilians, remain scarce. We aimed to replicate 45 SNPs associated with CRC risk and explore their correlation with genetic ancestry in a large Brazilian cohort. METHODS: A case-control study included 990 CRC cases and 1,027 controls in Brazil. We genotyped 45 SNPs using SNPtype assays and assessed ancestry with 46 ancestry informative markers. After matching cases and controls by sex and age, 906 cases and 906 controls were analyzed. RESULTS: Genotyping succeeded for 35 SNPs, and nine showed significant CRC associations. Multivariate analysis confirmed two SNPs linked to increased CRC risk, rs10795668 (odds ratio [OR], 1.98; P = .003) and rs6066825 (OR, 1.50; P = .008), and two SNPs with protective effects: rs4939827 (OR, 0.61; P = .001) and rs6983267 (OR, 0.65; P = .013). Low Asian (lowest tercile, OR, 1.48; P = .001) and low African (lowest tercile, OR, 1.22; P = .025) ancestry increased CRC risk. CONCLUSION: Our findings validated rs10795668 ( LOC10537640 ), rs4939827 ( SMAD7 ), rs6066825 ( PREX1 ), and rs6983267 ( CCAT2 ) polymorphisms in CRC risk among Brazilians and suggest that lower Asian and African ancestries might influence CRC susceptibility.